Serum CYFRA21-1 as a prognostic marker for patients with undifferentiated nasopharyngeal carcinoma

被引：20

作者：

Zhu, Wan-Qi ^{[1
]}

Yu, Jin-Ming ^{[1
]}

Sun, Xin-Dong ^{[1
]}

Xie, Peng ^{[1
]}

Kong, Li ^{[1
]}

机构：

[1] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan 250117, Shandong, Peoples R China

来源：

BIOMARKERS | 2010年 / 15卷 / 07期

关键词：

Nasopharyngeal carcinoma; undifferentiated; CYFRA21-1; CEA; prognosis; SQUAMOUS-CELL CARCINOMA; TUMOR-MARKERS; LUNG-CANCER; STAGE-I; HEAD; NECK; EXPRESSION; CYFRA-21-1; ANTIGEN; ADENOCARCINOMA;

D O I：

10.3109/1354750X.2010.504309

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The purpose of this study was to evaluate the potential of serum CYFRA21-1 and carcinoembryonic antigen (CEA) as prognostic markers in patients with undifferentiated nasopharyngeal carcinoma. Sixty-one patients who received definitive radiotherapy/chemoradiotherapy were analysed retrospectively. We investigated the association of the follow-up results with pretreatment level, post-treatment level and change of serum CYFRA21-1 and CEA, respectively. Patients with low pretreatment CYFRA21-1 had a significantly better overall survival. There were no significant associations among the remaining serum markers, and the survival and recurrence rates on multivariate analysis. The present study shows that pretreatment CYFRA21-1 level is a potential factor for predicting long-term survival.

引用

页码：602 / 607

页数：6

共 50 条

[21] Potential role of serum CYFRA 21-1 as a tumor marker for breast carcinoma
Evangelista, W
Martinotti, R
Mistrangelo, M
Bonazzi, G
Donadio, M
Ritorto, G
Satolli, M
Bertetto, O
EUROPEAN JOURNAL OF CANCER, 2002, 38 : S157 - S157
[22] Cyfra 21-1 marker in carcinoma of the cervix
Yazigi, R
Castillo, R
Aliste, G
Garrido, J
Opazo, A
Prado, S
Navarro, C
Altieri, E
Del Campo, G
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (03) : 203 - 206
[23] Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma
Ju, Mengyang
Ge, Xiaolin
Di, Xiaoke
Zhang, Yumeng
Liang, Liang
Shi, Yujing
FRONTIERS IN ONCOLOGY, 2022, 11
[24] CYFRA21-1与肺癌
李玲
邓海滨
上海医药, 2017, 38 (12) : 35 - 36
[25] Prognostic value of the pretreatment serum level of cytokeratin fraction 21-1 in undifferentiated nasopharyngeal carcinoma: A study of 332 cases
Wei, Zhengbo
Zeng, Xianjie
Xu, Jian
Duan, Xuwei
Yang, Jianbo
Xie, Ying
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (01): : 71 - 76
[26] 14-3-3σ expression as a prognostic marker in undifferentiated nasopharyngeal carcinoma
Chan, Sylvia Yat-Yee
To, Ka-Fai
Leung, Sing-Fai
Yip, William Wai-Lun
Mak, Michael Ko-Fung
Chung, Grace Tin-Yun
Lo, Kwok-Wai
ONCOLOGY REPORTS, 2010, 24 (04) : 949 - 955
[27] The Diagnostic Value of Serum Cytokeratin Fragment 19 (CYFRA21-1) for Thymic Squamous Cell Carcinoma
Shiiya, H.
Hida, Y.
Kaga, K.
Kato, T.
Aragaki, M.
Kubota, R.
Matsui, Y.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2063 - S2063
[28] Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma
Caviglia, Gian Paolo
Ciruolo, Michela
Olivero, Antonella
Carucci, Patrizia
Rolle, Emanuela
Rosso, Chiara
Abate, Maria Lorena
Risso, Alessandra
Ribaldone, Davide Giuseppe
Tandoi, Francesco
Saracco, Giorgio Maria
Bugianesi, Elisabetta
Gaia, Silvia
CANCERS, 2020, 12 (10) : 1 - 10
[29] Prognostic significance of preoperative serum CYFRA 21-1 in patients with upper urinary tract urothelial carcinoma
Suyama, Taisuke
Nakajima, Koichi
Kanbe, Shigeki
Tanaka, Norie
Hara, Hiroshi
Ishii, Nobuhisa
INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (01) : 43 - 47
[30] Prospective validation of serum CYFRA 21-1, β-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy
Ma, BBY
Leungm, SF
Hui, EP
Mo, F
Kwan, WH
Zee, B
Yuen, J
Chan, ATC
CANCER, 2004, 101 (04) : 776 - 781

← 1 2 3 4 5 →